AAAAAA
Results: 1-25/55
Authors:
Bezieau, S
Devilder, MC
Avet-Loiseau, H
Mellerin, MP
Puthier, D
Pennarun, E
Rapp, MJ
Harousseau, JL
Moisan, JP
Bataille, R
Citation: S. Bezieau et al., High incidence of N and K-Ras activating mutations in multiple myeloma andprimary plasma cell leukemia at diagnosis, HUM MUTAT, 18(3), 2001, pp. 212-224
Authors:
Ninin, E
Milpied, N
Moreau, P
Andre-Richet, B
Morineau, N
Mahe, B
Vigier, M
Imbert, BM
Morin, O
Harousseau, JL
Richet, H
Citation: E. Ninin et al., Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants, CLIN INF D, 33(1), 2001, pp. 41-47
Authors:
Levy, V
Porcher, R
Leblond, V
Fermand, JP
Cazin, B
Maloisel, F
Harousseau, JL
Remenieras, L
Guibon, O
Chevret, S
Citation: V. Levy et al., Evaluating treatment strategies in advanced Waldenstrom macroglobulinemia:use of quality-adjusted survival analysis, LEUKEMIA, 15(9), 2001, pp. 1466-1470
Authors:
Thomas, O
Mahe, MA
Campion, L
Bourdin, S
Milpied, N
Brunet, G
Lisbona, A
Le Mevel, A
Moreau, P
Harousseau, JL
Cuilliere, JC
Citation: O. Thomas et al., Long-term complications of total body irradiation in adults, INT J RAD O, 49(1), 2001, pp. 125-131
Authors:
Schmitt, C
Perel, Y
Harousseau, JL
Lemerle, S
Chwetzoff, E
le Moing, JP
Levron, JC
Citation: C. Schmitt et al., Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis, ANTIM AG CH, 45(5), 2001, pp. 1561-1564
Authors:
Attal, M
Harousseau, JL
Citation: M. Attal et Jl. Harousseau, Randomized trial experience of the Intergroupe Francophone du Myelome, SEM HEMATOL, 38(3), 2001, pp. 226-230
Authors:
Attal, M
Harousseau, JL
Citation: M. Attal et Jl. Harousseau, Randomized trials: experience of the intergroupe francais du myelome, B CANCER, 88(9), 2001, pp. 888-892
Authors:
Puthier, D
Thabard, W
Rapp, MJ
Etrillard, M
Harousseau, JL
Bataille, R
Amiot, M
Citation: D. Puthier et al., Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule, BR J HAEM, 112(2), 2001, pp. 358-363
Authors:
Leblond, V
Levy, V
Maloisel, F
Cazin, B
Fermand, JP
Harousseau, JL
Remenieras, L
Porcher, R
Gardembas, M
Marit, G
Deconinck, E
Desablens, B
Guilhot, F
Philippe, G
Stamatoullas, A
Guibon, O
Citation: V. Leblond et al., Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease, BLOOD, 98(9), 2001, pp. 2640-2644
Authors:
Avet-Loiseau, H
Gerson, F
Magrangeas, F
Minvielle, S
Harousseau, JL
Bataille, R
Citation: H. Avet-loiseau et al., Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors, BLOOD, 98(10), 2001, pp. 3082-3086
Authors:
Facon, T
Avet-Loiseau, H
Guillerm, G
Moreau, P
Genevieve, F
Zandecki, M
Lai, JL
Leleu, X
Jouet, JP
Bauters, F
Harousseau, JL
Bataille, R
Mary, JY
Citation: T. Facon et al., Chromosome 13 abnormalities identified by FISH analysis and serum beta(2)-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy, BLOOD, 97(6), 2001, pp. 1566-1571
Authors:
Harousseau, JL
Pignon, B
Chevalier, MP
Cahn, JY
Citation: Jl. Harousseau et al., Comparison of intensive chemotherapy and autologous transplantation as post remission therapy in adult acute myeloid leukemia. Update of the GOELAM 1trial, HEMAT BLOOD, 40, 2001, pp. 660-664
Authors:
Tiab, M
Mechinaud, F
Harousseau, JL
Citation: M. Tiab et al., Haemophagocytic syndrome associated with infections, BEST P R C, 13(2), 2000, pp. 163-178
Authors:
Brice, P
Simon, D
Bouabdallah, R
Belanger, C
Haioun, C
Thieblemont, C
Tilly, H
Harousseau, JL
Doyen, C
Martin, C
Brousse, N
Solal-Celigny, P
Citation: P. Brice et al., High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol, ANN ONCOL, 11(12), 2000, pp. 1585-1590
Authors:
Morineau, N
Tang, XW
Moreau, P
Milpied, N
Mahe, B
Bataille, R
Harousseau, JL
Citation: N. Morineau et al., Lack of benefit of CD34(+) cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single centerstudy, LEUKEMIA, 14(10), 2000, pp. 1815-1820
Authors:
Le Gouill, S
Talmant, P
Milpied, N
Daviet, A
Ancelot, M
Moreau, P
Harousseau, JL
Bataille, R
Avet-Loiseau, H
Citation: S. Le Gouill et al., Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia, J CL ONCOL, 18(7), 2000, pp. 1533-1538
Authors:
Harousseau, JL
Witz, B
Lioure, B
Hunault-Berger, M
Desablens, B
Delain, M
Guilhot, F
Le Prise, PY
Abgrall, JF
Deconinck, E
Guyotat, D
Vilque, JP
Casassus, P
Tournilhac, O
Audhuy, B
Solary, E
Citation: Jl. Harousseau et al., Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques, J CL ONCOL, 18(4), 2000, pp. 780-787
Salvage extended-field irradiation in follicular nonHodgkin's lymphoma after failure of chemotherapy
Authors:
Mahe, MA
Bourdin, S
Mevel, AL
Moreau, P
Campion, L
Hamidou, M
Milpied, N
Moreau, A
Gaillard, F
Harousseau, JL
Cuilliere, JC
Citation: Ma. Mahe et al., Salvage extended-field irradiation in follicular nonHodgkin's lymphoma after failure of chemotherapy, INT J RAD O, 47(3), 2000, pp. 735-738
Authors:
Vigouroux, S
Morin, O
Milpied, N
Mahe, B
Rapp, MJ
Harousseau, JL
Citation: S. Vigouroux et al., Cryptococcus neoformans infection in hematological malignancies., REV MED IN, 21(11), 2000, pp. 955-960
Authors:
Jego, G
Avet-Loiseau, H
Robillard, N
Moreau, P
Amiot, M
Harousseau, JL
Pellat-Deceunynck, C
Bataille, R
Citation: G. Jego et al., Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF, LEUK RES, 24(7), 2000, pp. 627-630
Authors:
Harousseau, JL
Dekker, AW
Stamatoullas-Bastard, A
Fassas, A
Linkesch, W
Gouveia, J
De Bock, R
Rovira, M
Seifert, WF
Joosen, H
Peeters, M
De Beule, K
Citation: Jl. Harousseau et al., Itraconazole oral solution for primary prophylaxis of fungal infections inpatients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazoleand amphotericin B, ANTIM AG CH, 44(7), 2000, pp. 1887-1893
Authors:
Harousseau, JL
Citation: Jl. Harousseau, Treatment of multiple myeloma, SCHW MED WO, 130(44), 2000, pp. 1649-1655
Authors:
Pellat-Deceunynck, C
Mellerin, MP
Labarriere, N
Jego, G
Moreau-Aubry, A
Harousseau, JL
Jotereau, F
Bataille, R
Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809
Authors:
Harousseau, JL
Zittoun, R
Bonneterre, J
Hedouin, M
Ouvry, J
Citation: Jl. Harousseau et al., Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination, B CANCER, 87(6), 2000, pp. 491-497
Authors:
Moreau, P
Harousseau, JL
Wijdenes, J
Morineau, N
Milpied, N
Bataille, R
Citation: P. Moreau et al., A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma, BR J HAEM, 109(3), 2000, pp. 661-664